Abstract: In this study, the effects of four strains of Lactobacillus paracasei LC2, LC3, LC38, and FJSWX33-L2 on constipation relief were evaluated, and the possible pathways of their differential effects were analyzed. Thirty-six Balb/c male mice were randomly divided into 6 groups. The normal group and the model group were intragastrically administered with 3% sucrose solution and the other groups were administered with L. paracasei for 14 days (109 CFU/ (d·each)). From the 15th day to the 30th day, except for the procedure same as the first 14 days, the suspension of loperamide was administered to establish a constipation model before gavage. The water content of the feces, the time to the first black stool and the rate of small bowel advancement were measured during the experiment; the levels of peptide tyrosine-tyrosine (PYY) and motilin in serum were determined; the levels of serotonin in the colon and neurotrophin-3 in the colon were measured; the transcription of Aqp4 and c-kit in the colon was detected; and the content of short-chain fatty acids (SCFAs) in the feces was also determined. All the four strains of L. paracasei showed the role of relieving constipation, while with differences in the pathway. LC2 could alleviate the constipation through the regulation on the level of PYY, NT-3, 5-HT, Aqp4, c-kit and SCFAs, whilst other three strains showed different ways to relieve constipation. It is indicated that L. paracasei has the potential to relieve constipation, while the effects on the constipation alleviation showed significant intra-species differences.
杨树荣,朱慧越,乌翛冰,等. 副干酪乳杆菌缓解由洛哌丁胺诱导的小鼠便秘的差异[J]. 食品与发酵工业, 2020, 46(2): 25-31.
YANG Shurong,ZHU Huiyue,WU Xiaobing,et al. Analysis on the different effects of Lactobacillus paracasei in relieving constipation induced by loperamide in mice[J]. Food and Fermentation Industries, 2020, 46(2): 25-31.
CHOI C H, CHANG S K. Alteration of gut microbiota and efficacy of probiotics in functional constipation[J]. Journal of Neurogastroenterology and Motility, 2015, 21(1):4-7.
[3]
MANCABELLI L, MILANI C, LUGLI G A, et al. Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses[J]. Scientific Reports, 2017, 7(1):9 879.
[4]
SINGH T P, KAUR G, MALIK R K, et al. Characterization of intestinal Lactobacillus reuteri strains as potential probiotics[J]. Probiotics & Antimicrobial Proteins, 2012, 4(1):47-58.
YANG Z H, YU H J, PAN A, et al. Cellular mechanisms underlying the laxative effect of flavonol naringenin on rat constipation model[J]. PLoS ONE, 2008, 3(10):e3 348.
[9]
LINLIN W, LUJUN H, QI X, et al. Bifidobacterium adolescentis exerts strain-specific effects on constipation induced by loperamide in BALB/c mice[J]. International Journal of Molecular Sciences, 2017, 18(2):318-340.
[10]
NUNOI H, MATSUURA B, UTSUNOMIYA S, et al. A relationship between motilin and growth hormone secretagogue receptors[J]. Regulatory Peptides, 2012, 176(1-3):28-35.
[11]
ZHAO X, SUO H, QIAN Y, et al. Therapeutic effects of Lactobacillus casei Qian treatment in activated carbon induced constipated mice[J]. Molecular Medicine Reports, 2015, 12(2): 3 191-3 199.
WANG L, GOURCAROL G, YUAN P Q, et al. Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice[J]. American Journal of Physiology Gastrointestinal & Liver Physiology, 2010, 298(1):45-56.
[14]
FEDERICO A, DALLIO M, TOLONE S, et al. Gastrointestinal hormones, intestinal microbiota and metabolic homeostasis in obese patients: Effect of bariatric surgery[J]. Vivo, 2016, 30(3):321-330.
SPENCER N J. Constitutively active 5-HT receptors: An explanation of how 5-HT antagonists inhibit gut motility in species where 5-HT is not an enteric neurotransmitter? [J]. Frontiers in Cellular Neuroscience, 2015,9:487-492.
[19]
LUND M L, EGEROD K L, ENGELSTOFT M S, et al. Enterochromaffin 5-HT cells - A major target for GLP-1 and gut microbial metabolites [J]. Molecular metabolism, 2018,11:70-83.
[20]
FUKUMOTO S, TATEWAKI M, YAMADA T, et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats[J]. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 2003, 284(5):R1 269-R1 276.
[21]
PARKMAN H P, RAO S S C, REYNOLDS J C, et al. Neurotrophin-3 improves functional constipation[J]. American Journal of Gastroenterology, 2003, 98(6):1 338-1 347.
[22]
COULIE B, SZARRKA L A, CAMILLERI M, et al. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans[J]. Gastroenterology, 2000, 119(1):41-50.
LI C, NIE S P, ZHU K X, et al. Effect of Lactobacillus plantarum NCU116 on loperamide-induced constipation in mice[J]. International Journal of Food Sciences and Nutrition, 2015, 66(5): 533-538.
[27]
IKARASHI N, KON R, SUGIYAMA K. Aquaporins in the colon as a new therapeutic target in diarrhea and constipation[J]. International Journal of Molecular Sciences, 2016, 17(7):1 172.
HURST N R, KENDIG D M, MURTHY K S, et al. The short chain fatty acids, butyrate and propionate, have differential effects on the motility of the guinea pig colon[J]. Neurogastroenterology & Motility, 2014, 26(11):1 586-1 596.
[33]
DASS N B, JOHN A K, BASSIL A K, et al. The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation[J]. Neurogastroenterology and Motility, 2007, 19(1):66-74.
2020, Vol. 46 
